Abstract INTRODUCTION Apolipoprotein E (APOE) ‐ε4 and social determinants of health (SDoH) are major Alzheimer's disease (AD) risk factors, yet whether SDoH modify the relationship between APOE‐ε4, AD pathology, and cognition remains unclear. METHODS Using Biobank for Aging Studies (BAS) data, we assessed APOE‐ε4 using...
Naomi V. Ferreira, L. Bertola, R. Paradela et al.· Alzheimer's & Dementia· 0 citations
Sleep phenotypes differ in progressive supranuclear palsy (PSP) and Alzheimer's disease (AD). The human intermediate nucleus (IntN), a putative ventrolateral preoptic analog, promotes non‐rapid eye movement (NREM) sleep, but its disease‐specific vulnerability is unclear.
Shima Rastegar-Pouyani, Caroline Lew, F. Pereira et al.· Alzheimer's & Dementia· 0 citations
BACKGROUND
Lewy body disease (LBD) is defined by neuronal α-synuclein pathology, but how Braak-staged LBD relates to mixed neuropathology and clinical manifestations within a single population-based cohort remains incompletely characterized. This is especially relevant in cohorts enriched for younger individuals, which...
Vitor Ribeiro Paes, Felipe L. Pereira, C. M. Silva et al.· Movement Disorders· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.